Fasilitas Baru untuk Hari Jadi ke-10 GenScript

AsiaNet 49510

PISCATAWAY, N.J., 31 Mei 2012 /PRNewswire-Asia-AsiaNet/ —

GenScript USA Inc., perusahaan bioteknologi terkemuka, mengumumkan
pembukaan fasilitas R&D baru di Nanjing, China.

Fasilitas baru ini akan memainkan peran utama dalam strategi GenScript
guna memperluas bisnis global dan menjangkau pasar berkembang di Asia.
GenScript berinvestasi sebesar USD$40 juta untuk membangun basis R&D baru di
area seluas 4.682.700 meter persegi di JiangNing Science Park. Pembangunan
fasilitas baru ini memecahkan rekor pada tahun 2009, dan tahap pertama
pembangunan basis R&D seluas 765.036 meter persegi telah selesai dengan tiga
bangunan berlantai lima dan bangunan rumah untuk hewan berlantai dua dengan
fasilitas AAALAC dan OLAW yang terakreditasi. Kondisi baru untuk peralatan
sintesis gen, purifikasi dan karakterisasi protein, teknik antibodi dan uji
obat-obatan telah dipasang di laboratorium penelitian. Dan fasilitas baru juga
menawarkan perkantoran, pusat pertemuan, kafetaria dan pusat latihan bagi
pekerja.

GenScript didirikan pada tahun 2002 sebagai perusahaan perintis yang
mengembangkan biologi sintesis dan saat ini adalah pemasok sintesis gen
terbesar di dunia. Dengan anak perusahaannya di Eropa, Jepang dan China, serta
berkantor pusat di New Jersey, GenScript konsisten dalam memberikan layanan
penelitian ilmiah untuk masyarakat di seluruh dunia. Selain layanan sintesis
gen terkemuka di dunia, GenScript menawarkan layanan komprehensif untuk
penelitian biologis dan penemuan obat tahap awal, seperti bio reagen,
pengembangan dan penyaringan pengujian, pengembangan obat antibodi, dan layanan
penelitian model hewan. Dengan mengembangkan dan menerapkan teknologi biologi
sintesis yang inovatif, GenScript membantu para peneliti mengembangkan
dan mengubah penelitian dalam biologi.

SUMBER: GenScript USA Inc.


A New Facility for the 10-Year Anniversary of GenScript

PISCATAWAY, N.J., May 31, 2012 /PRNewswire-Asia-AsiaNet/ —

GenScript USA Inc., a leading biotech company, has announced the opening of a new R&D facility in Nanjing, China.

This new facility will play a key role in GenScript’s strategy to expand its global business and to reach the emerging market in Asia. GenScript invested $40 million USD to build the new R&D base covering an area of 4,682,700 square feet in JiangNing Science Park. The construction of the new facility broke ground in 2009, and the first phase 765,036 square feet of the R&D base has recently been completed with three 5-story buildings, and two 2-story animal housing buildings with AAALAC and OLAW accredited facilities. New state of the art equipment for gene-synthesis, protein purification and characterization, antibody engineering and drug assays have been installed in the research labs. And the new facilities also offer offices, a meeting center, a cafeteria and an exercise center for employees.

Starting in 2002, GenScript, as a pioneer company, has grown together with the synthetic biology and is the now the world’s largest gene synthesis supplier. With subsidiaries in Europe, Japan, and China, and headquartered in New Jersey, GenScript consistently provides the best research services to the scientific community worldwide. Besides the world-leading gene synthesis service, GenScript offers comprehensive services for biological research and early-phase drug discovery, such as bio-reagents, assay development & screening, antibody drug development, and research animal model services. By developing and applying innovative synthetic biology technologies, GenScript assists researchers in advancing and transforming research in biology.

SOURCE: GenScript USA Inc.